DENYES NANCY 4
4 · aTYR PHARMA INC · Filed May 25, 2021
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
DENYES NANCY
General Counsel
Transactions
- Award
Employee Stock Option (Right to buy)
2021-05-21+59,000→ 59,000 totalExercise: $4.45Exp: 2025-05-21→ Common Stock (59,000 underlying)
Holdings
- 3,091
Common stock
Footnotes (2)
- [F1]Includes 178 shares acquired under that Company's 2015 Employee Stock Purchase Plan on May 17, 2021.
- [F2]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 21, 2021, such that this option will be fully exercisable on May 21, 2025. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.